Advisornet Financial’s Immunogen Inc IMGN Stock Holding History

Advisornet Financial’s Portfolio IMGN Stock Details IMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-25	Closed	–	–	1816
2019 Q1	$0	Hold	25	–	–	﹤0.01%	1674
2018 Q4	$0	Buy	+25	New	+$152	﹤0.01%	1596

Other funds holding IMGN

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Advisornet Financial's IMGN Position: Q2 2019 in Review

Advisornet Financial sold out of Immunogen Inc (IMGN) in Q2 2019, closing a stake of 25 shares.

Advisornet Financial first reported a position in IMGN in Q4 2018 and held it in 2 quarters. The position peaked at $0 in Q1 2019. 192 funds tracked by Wall St. Rank hold IMGN as of Q2 2019.

Advisornet Financial reported no remaining Immunogen Inc position as of Q2 2019 after selling out during the quarter.
Advisornet Financial sold 25 Immunogen Inc shares in Q2 2019.
Advisornet Financial first reported a position in Immunogen Inc in Q4 2018 and held it in 2 quarters.
Advisornet Financial's Immunogen Inc position peaked at $0 in Q1 2019.
192 funds tracked by Wall St. Rank held Immunogen Inc as of Q2 2019.

Based on Advisornet Financial's 13F filing for Q2 2019, filed 15 Jul 2019.